POUCO CONHECIDO FATOS SOBRE FDA APPROVED OBSTRUCTIVE SLEEP APNEA TREATMENT.

Data indicate that the Inspire device reduces sleep apnea by an average of 79% and significantly reduces snoring and daytime sleepiness. In addition to daytime tiredness and irritability, people with sleep apnea are at higher risk for stroke, type 2 diabetes, metabolic syndrome and liver problems.APAP machines deliver a lower average air pressure c

Patients also need long-term follow up with an annual office visit to check equipment, titrate settings as needed, and to ensure ongoing mask and interface fit. Continuing patient education on the importance of regular use and support groups help patients obtain the maximum benefit of this therapy.Expiratory positive airway pressure (EPAP) therapy: